US2007066575A1PendingUtilityA1

Methods and compositions for mitigating pain

52
Assignee: UNIV KINGSTONPriority: Dec 29, 1999Filed: Aug 22, 2006Published: Mar 22, 2007
Est. expiryDec 29, 2019(expired)· nominal 20-yr term from priority
A61P 25/20A61P 25/22A61P 29/00A61P 25/04C07C 317/18C07D 307/33C07D 277/24C07C 327/28A61K 31/385A61K 31/426C07F 9/4006C07C 323/20C07D 207/337A61K 31/5375A61K 31/39C07D 333/48C07C 331/10C07C 323/58A61K 31/381A61K 31/04C07D 333/44C07D 317/60C07J 41/0055C07D 491/04A61K 31/275C07F 9/3808C07D 409/04C07D 311/16C07C 205/40C07D 295/088C07C 309/12C07C 203/06C07D 339/08C07D 207/16A61P 23/00C07D 487/04C07J 41/0061C07D 327/04C07C 323/12A61K 31/21C07C 323/62A61K 31/00C07C 203/04
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods and therapeutic compounds for treating pain, mitigating inflammation, effecting analgesia and/or effecting sedation in a subject are described. A subject is administered an effective amount of a therapeutic compound which is a nitrate ester. Novel pharmaceutical compositions are also described.

Claims

exact text as granted — not AI-modified
1 . A method for treating pain in a subject in need thereof, comprising administering to the subject an effective amount of a therapeutic compound, wherein said therapeutic compound is of the formula (Ia):  
     
       
         
         
             
             
         
       
       F 2  is a nitrate group or an organic radical which may be joined in a cyclic ring system with  
       G 2 , and which may contain inorganic counterions;  
       E is a methylene group;  
       G 1  is a methylene group or does not exist;  
       F 1  is H; and  
       G 2  is joined with F 2  to form a cyclic system or is R N -Z N ; wherein R N  is an organic radical possessing a heteroaryl group containing a P or S atom, where said P or S is positioned β, γ, or δ to a nitrate group; and Z N  is W N   nwn -X N   nn -Y N   oo ; wherein  
       mm, nn, oo are 0 or 1 and W N , X N , Y N  are NH, NR NN , CO, O, or CH 2 ; wherein  
       R NN  is a C 1 -C 12  alkyl group.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.